Recent genome-wide association studies have linked common variants in the human genome
to Parkinson's disease (PD) risk. Here we show that the consequences of variants at 2 …

Understanding the tissue-specific genetic controls of protein levels is essential to uncover
mechanisms of post-transcriptional gene regulation. In this study, we generated a genomic …

Directed conversion of mature human cells, as from fibroblasts to neurons, is of potential
clinical utility for neurological disease modeling as well as cell therapeutics. Here, we describe …

Progranulin (PGRN, encoded by the GRN gene) plays a key role in the development, survival,
function, and maintenance of neurons and microglia in the mammalian brain. It regulates …

SARS-CoV-2 is associated with broad tissue tropism, a characteristic often determined by
the availability of entry receptors on host cells. Here, we show that TMEM106B, a lysosomal …

Late-onset Alzheimer’s disease (LOAD) risk is strongly influenced by genetic factors such
as the presence of the apolipoprotein E ε4 allele (referred to here as APOE4), as well as non-…

Proteomic studies for Alzheimer’s disease (AD) are instrumental in identifying AD pathways
but often focus on single tissues and sporadic AD cases. Here, we present a proteomic study …

α-Synuclein is implicated both in physiological functions at neuronal synaptic terminals as
well as in pathological processes in the context of Parkinson's disease. However, the …

TREM2 is a receptor for lipids expressed in microglia. The R47H variant of human TREM2
impairs ligand binding and increases Alzheimer’s disease (AD) risk. In mouse models of …

Human age-associated traits, such as cognitive decline, can be highly variable across the
population, with some individuals exhibiting traits that are not expected at a given …